Health Insurance - Scalp Cooling Systems - Required Coverage
Summary
SB0272 requires certain Maryland health insurers, nonprofit health service plans, health maintenance organizations, and managed care organizations to cover scalp cooling systems when they already provide coverage for chemotherapy to treat cancer. The bill defines a scalp cooling system as a reusable device used to cool the scalp to help prevent or reduce hair loss associated with chemotherapy, and limits the mandate to devices primarily used for a medical purpose.
The coverage requirement applies to health insurance policies, contracts, and health benefit plans issued or delivered in Maryland by the specified carriers. The mandate does not create a general requirement for all cancer-related care; it is tied specifically to chemotherapy coverage and the use of scalp cooling systems for hair preservation during treatment. The law takes effect January 1, 2027, and applies to policies and plans issued, delivered, or renewed on or after that date.
Impact
This bill amends the Maryland Insurance Article by adding a new section, Section 15-864, establishing a new mandated health insurance benefit. It affects insurers, nonprofit health service plans, HMOs, and managed care organizations operating in Maryland by requiring them to include scalp cooling system coverage whenever they cover chemotherapy for cancer treatment. The practical impact is to expand insured access to a supportive cancer-treatment device and potentially shift some costs from patients to carriers, subject to the bill’s effective date and renewal timing.
Sentiment
The bill appears to have been broadly supported and noncontroversial in the legislative process. It passed the Senate 43-0 and the House 122-6, and there is no committee transcript indicating significant debate or opposition. The strong vote margins suggest general agreement that the coverage mandate is a modest, patient-supportive insurance benefit.
Contention
No major points of contention are reflected in the available record. The only likely policy issue is the cost and administrative impact on insurers from adding a new mandated benefit, but the voting history suggests that any such concerns did not generate substantial opposition. The bill’s supporters appear to have viewed scalp cooling coverage as a cancer-care support measure, while any dissent was limited and not documented in the provided materials.